|
Volumn 92, Issue 22, 2000, Pages 1823-1830
|
Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CD4 ANTIGEN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BRAIN LYMPHOMA;
CANCER INCIDENCE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HUMAN TISSUE;
INCIDENCE;
KAPOSI SARCOMA;
META ANALYSIS;
MORTALITY;
MULTICENTER STUDY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTI-HIV AGENTS;
AUSTRALIA;
EUROPE;
FEMALE;
HODGKIN DISEASE;
HUMANS;
INCIDENCE;
INTERNATIONAL COOPERATION;
LYMPHOMA, AIDS-RELATED;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
NEOPLASMS;
NORTH AMERICA;
ODDS RATIO;
SARCOMA, KAPOSI;
UTERINE CERVICAL NEOPLASMS;
|
EID: 0034669127
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (641)
|
References (19)
|